|
SAR1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.6221999561169E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92710003510399E-09 |
| Normal-vs-Stage2 |
5.796100E-03 |
| Normal-vs-Stage3 |
2.524000E-02 |
| Normal-vs-Stage4 |
6.783900E-02 |
| Stage1-vs-Stage2 |
1.429630E-01 |
| Stage1-vs-Stage3 |
9.435700E-02 |
| Stage1-vs-Stage4 |
1.156810E-01 |
| Stage2-vs-Stage3 |
7.323200E-01 |
| Stage2-vs-Stage4 |
7.397000E-01 |
| Stage3-vs-Stage4 |
9.641200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.90959955917947E-10 |
| Normal-vs-AfricanAmerican |
1.54846999999014E-05 |
| Normal-vs-Asian |
8.197400E-01 |
| Caucasian-vs-AfricanAmerican |
3.889800E-01 |
| Caucasian-vs-Asian |
2.747000E-01 |
| AfricanAmerican-vs-Asian |
3.374800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.96589983076012E-10 |
| Normal-vs-Female |
6.4046999999956E-05 |
| Male-vs-Female |
1.987370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.415000E-04 |
| Normal-vs-Extreme_Weight |
6.13509998359518E-09 |
| Normal-vs-Obese |
5.85930000074342E-08 |
| Normal-vs-Extreme_Obese |
8.875400E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.391800E-01 |
| Normal_Weight-vs-Obese |
5.613800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.810400E-01 |
| Extreme_Weight-vs-Obese |
9.888800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.953400E-01 |
| Obese-vs-Extreme_Obese |
4.212000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.399300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.70583999999918E-05 |
| Normal-vs-Age(61-80Yrs) |
5.02720087780517E-11 |
| Normal-vs-Age(81-100Yrs) |
5.819700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.621800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.855600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.079000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.502100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.290200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.946990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65789604267275E-12 |
| Normal-VS-Type2 PRCC |
6.097600E-02 |
| Normal-VS-KIRP CIMP |
2.28469999996594E-06 |
| Normal-VS-Unclassified PRCC |
3.78400000000667E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.56010999999845E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.611900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.605580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.68209999999692E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.121680E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.080400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.174900E-04 |
| Normal-vs-N1 |
4.796100E-03 |
| Normal-vs-N2 |
4.060800E-03 |
| N0-vs-N1 |
9.988600E-01 |
| N0-vs-N2 |
3.112400E-01 |
| N1-vs-N2 |
3.943800E-01 |
|
|
